"New state laws tackle the burden of medical debt and the corporate take-over of medicine."

Meaningful opportunities to reduce U.S. health-care costs already exist but are often overshadowed by the focus on more politically prominent proposals.

Interview by Rob Lott

The article explains how growing consolidation among insurers, hospitals, and physician groups is driving higher prices and fewer choices for patients, while current antitrust tools struggle to keep up with these increasingly complex mergers.

Researchers found UnitedHealthcare paid 17% more to Optum than to other providers.

Researchers said the results suggest UnitedHealth may be sidestepping government rules meant to keep a lid on exorbitant payer profits.

This article quotes Brown University researchers Chris Whaley and Roslyn Murray from the CAHPR, who explain that wide hospital price differences across Rhode Island stem less from care quality and more from market consolidation. Whaley noted that “there’s really not a strong relationship between price and quality,” while Murray pointed to “empire-building tactics” and consolidation that give large health systems leverage to raise prices and obscure transparency

This article discusses a Brown University study showing that commercial insurers pay nearly $1,500 more per procedure at hospital outpatient departments than at ambulatory surgical centers. The findings highlight large price variations across insurers and suggest opportunities for cost savings through selective contracting or site-neutral payment reforms.

Hospitals are discouraging infection testing to avoid Medicare penalties, a practice clinicians say jeopardizes patient safety and skews public reporting. As Brown University’s Andrew Ryan put it, “Basically, the measures are just really, really bad … this is honestly the worst” pay-for-performance program, underscoring deep flaws in how infection penalties are designed and enforced.

Republican lawmakers pressed for stricter oversight of nonprofit hospitals at a House hearing, arguing that many exploit tax exemptions while providing limited charity care. Witnesses, including Brown University’s Christopher Whaley, highlighted that current reporting structures obscure hospital-level community benefit, and urged stronger, more transparent requirements to ensure accountability.

In testimony before Congress, Brown University researcher Christopher Whaley revealed that many nonprofit hospitals reap massive financial benefits yet spend far less on community health than their tax exemptions are worth. With bipartisan concern mounting, Whaley urged reforms to ensure tax breaks translate into affordable, high-quality care for patients — not executive perks or stadium sponsorships.

This article reports on a Health Affairs study led by Brown University researchers analyzed over a decade of private equity acquisitions in opioid treatment programs across 43 states. The findings show that despite rapid growth in private equity ownership, there were no measurable improvements in methadone access, treatment expansion, or opioid-related mortality

A new Health Affairs study reveals that hundreds of urban hospitals have secured “Medicare administratively rural” status—unlocking benefits meant for rural communities. While CMS prepares to roll out its $50 billion Rural Health Transformation Program, the findings raise concerns about loopholes, misaligned incentives, and whether subsidizing facilities truly improves access for rural patients.

This article talks about a Health Affairs study led by researchers at CAHPR, University of Pittsburgh and the RAND Corporation on the current PE ownership of opioid treatment programs in the US. Despite acquiring large shares of the market, PE firms are not expanding access to methadone—leaving the treatment gap largely unchanged.

In the first half of 2025, states enacted numerous laws to strengthen their health care markets. These new laws address several recurring policy issues affecting states across the country, including skyrocketing health care costs, increased consolidation in the healthcare sector, and the heightened penetration of private equity in health care systems.

The proposed sale of two safety net hospitals — from private equity-backed Prospect Medical Holdings to the nonprofit Centurion Foundation — has been closely watched across the state. The Attorney General's updated terms for the sale reflect growing concern over the role of private equity in Rhode Island’s health care system.

Drugmakers are experimenting with direct-to-consumer sales in response to Trump’s push for lower drug prices, aiming to bypass traditional middlemen like PBMs. While the strategy could reshape how patients access medications, experts warn its impact on affordability, safety, and equity remains uncertain.

The article investigates how major drugmakers like Pfizer and Eli Lilly are paying telehealth companies millions of dollars to connect patients to providers, raising concerns about potential conflicts of interest and violations of anti-kickback laws. While both companies deny influencing prescriptions, lawmakers and experts worry these partnerships may steer patients toward expensive branded drugs and allow pharma firms to collect detailed patient data.

This article covers a study in JAMA Health Forum finds that private equity-acquired gastroenterology practices significantly raised colonoscopy prices without any improvement in quality of care. The rise in costs was especially steep in highly consolidated markets, where prices surged by 6.7%. With no measurable gains in patient outcomes, the findings raise broader concerns about the impact of PE’s profit-driven model on healthcare affordability, transparency, and value.

This article argues that despite Massachusetts’ recent reforms after the collapse of Steward Health Care, a major loophole still allows private equity to control medical practices through shell companies and “friendly physician” arrangements. Drawing on the century-old corporate practice of medicine (CPOM) doctrine, the article calls for stronger legal restrictions like those recently passed in Oregon to protect patient care from financial interests.

This article reports on a study by Daniel R. Arnold, and colleagues who find that private equity-acquired gastroenterology practices significantly increase colonoscopy prices—by 4.5% more than independent practices—without improving care quality. Despite claims that consolidation boosts efficiency, the analysis showed no statistical difference in quality measures, raising concerns about affordability and access.

This article reports on a FTC study highlighting how roll-up acquisitions of physician practices—often led by private equity firms—can harm competition, raise prices, and reduce care quality. The study calls for increased scrutiny of serial acquisitions that fall below federal reporting thresholds, and experts say it could lead to stronger antitrust enforcement in healthcare markets.

This article discusses how financial pressures, staffing shortages, and management decisions at Wisconsin’s Group Health Cooperative have led to a unionization effort by primary care providers, reflecting broader national challenges facing independent primary care.

Professors Erin Fuse Brown and Yashaswini Singh warn that private equity’s focus on short-term returns is reshaping healthcare at the expense of patients and providers. From overburdened hospitals to ethical dilemmas in mental health care, their insights expose how profit-driven ownership can undermine clinical priorities and public trust.

The Trump administration's push for deregulation threatens to accelerate vertical integration in healthcare. Brown University professor, Dr. Christopher Whaley warns from existing research how this may lead to referrals to more expensive hospitals ultimately leading to higher costs, reduced competition, and financial strain on independent hospitals, particularly in rural areas as the article discusses.

The article covers a study published in JAMA Health Forum by Yashaswini Singh and colleagues on the increasing affiliation of primary care physicians with hospitals and private equity firms, leading to higher patient costs without clear improvements in care quality or physician compensation.

This article discusses a study led by Dr. Yashaswini Singh and published in JAMA Health Forum on trends in physician practice ownership, showing a significant shift from independent practices to corporate ownership, as well as the associated price increases, with hospital and PE-affiliated practices charging higher fees, and its implications for healthcare costs and quality.

This article highlights the study led by Dr. Yashaswini Singh on the growing affiliation of primary care physicians with hospitals and private equity firms along with increasing healthcare costs that come with these affiliations.

Physicians, traditionally less unionized, are aligning with nurses and other healthcare workers due to shared grievances over understaffing, burnout, and corporate cost-cutting practices exacerbated by the pandemic. Hayden Rooke-Ley comments on this trend highlighting his study that found that the number of physician unions formed between January 2023 and May 2024 nearly equaled those established over the previous two decades (2000–2022).

A new Harvard Medical School study found that patient satisfaction declines after PE takeovers due to cost-cutting measures, including staffing reductions. Dr. Yashaswini Singh from CAHPR comments on how patient experiences are crucial to understanding the broader effects of PE in healthcare, a frequently underrated aspect in studies on PE's impact on healthcare.

The article discusses the proposed merger of Oregon Health & Science University (OHSU) and Legacy Health, which has drawn significant criticism for potentially violating federal antitrust standards. Advocates argue the merger would lead to excessive market consolidation in Oregon, controlling a majority of hospitals in key regions and potentially driving up healthcare costs without improving access or quality.

This article highlights a study led by Dr. Christopher Whaley that shows that while system affiliation helps improve CAHs’ financial stability, it often results in higher prices for patients.

This article explores the study by researchers from Johns Hopkins University and CAHPR at Brown University, which examines financial disparities between critical access hospitals (CAHs) and larger acute care hospitals from 2016 to 2022. The study highlights significant financial disparities, showing that system-affiliated critical access hospitals (CAHs) achieved higher operating margins than independent ones and highlights the need to balance financial sustainability with the risks of uneven care access and higher prices.

This article dives into the controversial world of private equity in healthcare, where profit-driven strategies lead to higher patient costs and declining care quality. This article examines real examples, from staffing cuts to surprise billing, and explores how these changes threaten physician autonomy and the stability of U.S. healthcare.

The article examines California’s failed attempt to regulate private equity investments in healthcare through AB 3129, which proposed stricter transaction oversight and protections against corporate control of medical practices. It critiques the bill’s limited scope, exemptions, and political challenges while positioning it as a case study for future state-level reforms in addressing healthcare consolidation.

This article highlights a study by Christopher Whaley showing how hospitals have received billions in extra payments by documenting care at higher levels of complexity than expected. This practice, known as "upcoding," raises concerns about the incentives in current payment systems and their impact on rising healthcare costs.

The article written by CAHPR researchers, emphasizes the opportunity for Congress, in its final weeks of the 118th session, to advance healthcare affordability and transparency through the Lower Costs, More Transparency Act (LCMT) and the Health Care PRICE Transparency Act 2.0

UnitedHealth Group's insurance arm, UnitedHealthcare, pays its own Optum physician practices significantly higher rates than other providers in the same markets, driving up costs for consumers and employers while enriching itself. This practice highlights the conflicts of interest and anti-competitive effects of vertical integration in healthcare, raising calls for regulatory intervention.

Is Medicare Advantage improving healthcare efficiency or creating higher costs that favor insurers? Hayden Rooke-Ley explores its rapid expansion, questions about cost and care quality, and the challenges of implementing effective regulations.

This article outlines six key points about Oregon's regulatory review of the OHSU-Legacy merger. Hayden Rooke-Ley's critique of the OHSU-Legacy merger, emphasizing how OHSU's broad market definition may obscure significant anticompetitive risks, presenting a critical test for Oregon's Health Care Market Oversight program.

This article examines the Oregon Health Authority's comprehensive review of the proposed merger between OHSU and Legacy Health, highlighting key concerns about market concentration, potential cost increases, and the future of health care access and competition in the region.

The article exposes Ralph de la Torre's misuse of private equity-backed Steward Health for personal gain while highlighting the broader issue of private equity's damaging impact on healthcare, with legislative efforts for reform largely stymied by political and lobbying pressures.

This article explores how private equity firms have taken control of many U.S. emergency rooms, prioritizing profit by reducing physician hours, replacing doctors with less qualified staff, and inflating costs, resulting in compromised patient care and increased bills, despite regulatory efforts like the No Surprises Act.

CAHPR researchers examine the economic and healthcare implications of consolidation within the U.S. healthcare system while proposing legislative solutions aimed at curbing the adverse effects of consolidation.

The FTC's nationwide ban on non-compete agreements, originally set to take effect on September 4, 2024, is now entangled in legal battles that challenge the agency's authority. This article explores the ongoing debates, highlighting the loopholes in the current rule, and prescribes potential policy solutions.

Christopher Whaley testified before Congress, highlighting the urgent need of health care price transparency and its role in combating high healthcare costs in the US and enhancing policy decision-making.

Dr. Ashish K. Jha, dean of the Brown University School of Public Health, addressed the House Committee on Ways and Means on why the U.S. is seeing a decline in private medical practices and what we can do about it.

Healthcare consolidation is fueled by the need for pricing power and financial stability under value-based care, but experts warn this trend threatens competition and transparency, calling for stronger oversight and legislative action.

The PE firm, Welsh, Carson, Anderson & Stowe has been released from the ongoing case against U.S. Anesthesia Partners, for monopolization in Texas. What does this mean for PE firms and antitrust scrutiny?

Is private equity good AND bad? Listen to experts including Dr. Yashaswini Singh talk about private equity with a nuanced approach.